S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMS
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843668.08766.86 |
| _version_ | 1797287912874704896 |
|---|---|
| author | M. H. Wildschut M. van Oostrum J. Settelmeier J. Mena C. Dördelmann Y. Festl A. Ring R. C. Skoda M. Lopes B. Wollscheid B. Snijder A. Theocharides |
| author_facet | M. H. Wildschut M. van Oostrum J. Settelmeier J. Mena C. Dördelmann Y. Festl A. Ring R. C. Skoda M. Lopes B. Wollscheid B. Snijder A. Theocharides |
| author_sort | M. H. Wildschut |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:42Z |
| format | Article |
| id | doaj.art-896815fa9f45488ebdf467efaa76c671 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:42Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-896815fa9f45488ebdf467efaa76c6712024-03-02T03:51:40ZengWileyHemaSphere2572-92412022-06-016959610.1097/01.HS9.0000843668.08766.86202206003-00095S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMSM. H. Wildschut0M. van Oostrum1J. Settelmeier2J. Mena3C. Dördelmann4Y. Festl5A. Ring6R. C. Skoda7M. Lopes8B. Wollscheid9B. Snijder10A. Theocharides111 Institute of Molecular Systems Biology, Department of Biology2 Institute of Translational Medicine, Department of Health Science and Technology, ETH Zurich2 Institute of Translational Medicine, Department of Health Science and Technology, ETH Zurich1 Institute of Molecular Systems Biology, Department of Biology5 Insititute of Molecular Cancer Research, University of Zurich, Zurich1 Institute of Molecular Systems Biology, Department of Biology3 Department of Medical Oncology and Hematology, Division of Hematology, University Hospital Zurich, Zurich6 Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland5 Insititute of Molecular Cancer Research, University of Zurich, Zurich2 Institute of Translational Medicine, Department of Health Science and Technology, ETH Zurich1 Institute of Molecular Systems Biology, Department of Biology3 Department of Medical Oncology and Hematology, Division of Hematology, University Hospital Zurich, Zurichhttp://journals.lww.com/10.1097/01.HS9.0000843668.08766.86 |
| spellingShingle | M. H. Wildschut M. van Oostrum J. Settelmeier J. Mena C. Dördelmann Y. Festl A. Ring R. C. Skoda M. Lopes B. Wollscheid B. Snijder A. Theocharides S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMS HemaSphere |
| title | S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMS |
| title_full | S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMS |
| title_fullStr | S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMS |
| title_full_unstemmed | S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMS |
| title_short | S194: INTEGRATIVE CLINICAL PROTEOTYPING AND DRUG RESPONSE PROFILING IDENTIFIES TARGETABLE BIOLOGY UNDERLYING MYELOPROLIFERATIVE NEOPLASMS |
| title_sort | s194 integrative clinical proteotyping and drug response profiling identifies targetable biology underlying myeloproliferative neoplasms |
| url | http://journals.lww.com/10.1097/01.HS9.0000843668.08766.86 |
| work_keys_str_mv | AT mhwildschut s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT mvanoostrum s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT jsettelmeier s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT jmena s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT cdordelmann s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT yfestl s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT aring s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT rcskoda s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT mlopes s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT bwollscheid s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT bsnijder s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms AT atheocharides s194integrativeclinicalproteotypinganddrugresponseprofilingidentifiestargetablebiologyunderlyingmyeloproliferativeneoplasms |